Voyager Therapeutics: Insider Stock‑Option Surge Signals Confidence, Raises Dilution Concerns
Voyager Therapeutics insider activity signals confidence in its gene‑therapy pipeline—but the new option pool also raises dilution concerns as the company gears up for a capital raise.
3 minutes to read
